Drugs in development: bisphosphonates and metalloproteinase inhibitors

AUTOR(ES)

Catterall, Jon B

FONTE

BioMed Central

RESUMO

The destruction of bone and cartilage is characteristic of the progression of musculoskeletal diseases. The present review discusses the developments made with two different classes of drugs, the bisphosphonates and matrix metalloproteinase inhibitors. Bisphosphonates have proven to be an effective and safe treatment for the prevention of bone loss, especially in osteoporotic disease, and may have a role in the treatment of arthritic diseases. The development of matrix metalloproteinase inhibitors and their role as potential therapies are also discussed, especially in the light of the disappointing human trials data so far published.

Documentos Relacionados

• The role of bisphosphonates in breast cancer: Development of bisphosphonates
• US drugs regulator issues severe pain alert on bisphosphonates
• Sustainable development: conceptualizations and measurement
• Genes and Development: Molecular and Logical Themes
• Collection Management and Development: Issues in an Electronic Era